Health & WellnessGlobal (GL)
stat+: roche gets a lung cancer win with its kras drug divarasib
First reported: 23h agoUpdated: 23h ago1 source covering
⚠️ Content Notice
This story relates to health or medical topics. HeadlineSift's AI-generated summaries are for informational purposes only and do not constitute medical advice, diagnosis, or treatment recommendations. Always consult a qualified healthcare professional for medical decisions.
AI analysis is pending for this story. Check back soon.
Sources & Attribution
STAT News
861 article
Original Articles (1)
STAT+: Roche gets a lung cancer win with its KRAS drug divarasib
Read original →STAT News·Adam Feuerstein and Andrew Joseph·Monday, October 26, 2026 11:17 PM